Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Silodosin Effective for Treating Lower Urinary Tract Symptoms in Female Patients With Multiple Sclerosis? A Randomized Controlled Trial

NCT07614321 is registered in ClinicalTrials.gov with Atlantic Health System as lead sponsor.

NCT NCT07614321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07614321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Silodosin Effective for Treating Lower Urinary Tract Symptoms in Female Patients With Multiple Sclerosis? A Randomized Controlled Trial
Lead sponsor
Atlantic Health System
Phase
Phase 4
Overall status
Recruiting
Start date
April 30, 2026
Completion date
April 30, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower urinary track symptoms, multiple sclerosis